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Involvement of GTP-binding proteins in angiotensin II-induced mobilization of calcium has been examined 
in adrenal glomerulosa cells by using pertussis toxin. Pretreatment of glomerulosa cells with pertussis toxin 
abolishes angiotensin II-induced calcium influx without blocking inositol trisphosphate production. These 
results suggest a role of the pertussis toxin-sensitive GTP-binding protein in transducing angiotensin II-re- 
ceptor occupancy into opening of calcium channel. 
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1. INTRODUCTION 
Angiotensin II stimulates aldosterone secretion 
in adrenal glomerulosa cells b3 a calcium- 
dependent mechanism [ 1,2]. This hormone induces 
two major alterations in cellular calcium handling: 
a rapid but transient release of calcium from an in- 
tracellular non-mitochondrial pool(s) [3] and a sus- 
tained elevation of calcium influx rate [4], both of 
which are important in the action of ~~otensin II 
[5]. Several lines of evidence indicate that calcium 
release is mediated by inositol 1,4,5trisphosphate 
(Ins-P3): (i) angiotensin II rapidly increases Ins-P, 
by activating phospholipase C specific to 
phosphatidylinositol 4,5-bisphosphate [6,7]; (ii) 
Ins-P3 causes a release of calcium from the non- 
mitochondrial pool in permeabilized glomerulosa 
cell [6]; (iii) dantrolene, which inhibits Ins- 
P3-induced calcium release in permeabilized cell 
[6], also attenuates the action of angiotensin II on 
calcium release in intact glomerulosa cell 131. Thus, 
an activation of phospho~~se C is the initial step 
to mobilize calcium from the intracellular pool. In 
contrast, the mechanism by which angiotensin II 
stimulates calcium influx remains unknown. It is 
even unclear whether or not stimulation of calcium 
influx is a consequence of phosphoinositide 
breakdown. 
Recent studies have demonstrated that GTP- 
binding proteins are involved in the action of 
calcium-mobilizing agonists. In cell free system, 
GTP enhances agonist-induced activation of 
phospholip~e C [8-12]. Further support for the 
notion that GTP-binding proteins are involved in 
the action of calcium-mobilizing agonists is ob- 
tained by using pertussis toxin, which ADP- 
ribosylates the inhibitory coupling protein, Ni, and 
blocks its action [13]. Pertussis toxin is shown to 
Bttenuate ago~st-indu~ breakdown of poly- 
>hosphoinositide [14-161 and changes in ion 
fluxes [17,181 insome systems. Thus, pertussis tox- 
in provides a useful tool to assess an involvement 
of GTP-binding protein, particularly Ni, in the ac- 
tion of ~~~-rnobil~ agonists. 
In the present study, we have examined the ef- 
fect of pertussis toxin treatment on angiotensin II- 
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induced calcium mobilization in adrenal 
glomerulosa cells. Results indicate that pertussis 
toxin blocks angiotensin II-mediated increase in 
calcium influx without in~biting calcium release 
from an intracellular pool. 
2. MATERIALS AND METHODS 
Isolated bovine adrenal glomerulosa cells were 
prepared by a collagenase digestion method [7]. 
Cells were incubated in modified Hanks solution 
containing (in mM) 137 NaCl, 3.5 KCl, 0.44 
KH~P04,4.2 NaHCO3,0.33 NazHP04,0.5 CaClz 
and 20 Hepes/NaOH (pH 7.4), equilibrated with 
02 gas. For pertussis toxin treatment, cells were in- 
cubated in modified Hanks solution containing 
pertussis toxin for 1 h. When cells were incubated 
in medium containing low extracellular calcium 
concentration, Ca”-EGTA buffer was employed 
[4]. Changes in cytoplasmic free calcium concen- 
tration ([Cat’],) were measured with a calcium- 
sensitive photoprotein, aequorin [ 191. Aequorin 
was introduced into glomerulosa cells by the 
method of Morgan and Morgan l20] as described 
[21]. Cell suspension containing 10’ cells in 1 ml 
was incubated in a cuvette at 37°C under constant 
stirring and aequorin biolu~nescen~ was 
measured as described [21]. [Cat’], is not 
calibrated since no information is available at pre- 
sent as to the spatial distribution of calcium in the 
cell. Aequorin luminescence is expressed as electric 
current. Traces presented are representative of at 
least three experiments with similar results. 
Calcium infhtx rate was obtained by measuring 
an initial uptake of 45Ca into glomerulosa cells [4]. 
Protein content was measured according to Brad- 
ford [22] using bovine &obulin as standard. 
Production of Ins-P3 was measured using 
[3~inositol-la~l~ cells as described [21]. After a 
2 h labeling period, cells were washed and further 
incubated for 1 h in modified Hanks solution con- 
taining 10 mM inositol and 10 mM lithium 
chloride in the. pre$ence and absence of pertussis 
toxin. Cells were then stimulated by an8iotensin II 
for 20 and 60 s and the reaction was terminated by 
adding perchlorate (final concentration of 10%). 
Cells were homogenized by repetitive aspirations 
through a 26 G needle. The homogenate was cen- 
trifuged at 800 x g for 5 min, supernatant 
neutralized by adding 1 M KOH and applied onto 
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an anion exchange column. ]3H]Inositol 
trisphosphate was eluted as described by Berridge 
et al. 123). 
Pertussis toxin was a generous gift of Professor 
Michio Ui, Hokkaido University, Sapporo, Japan. 
Aequorin was purchased from Dr J.R. Blinks of 
Mayo Foundation (Rochester, MN). Angiotensin 
II was obtained from Sigma (St. Louis, MO). 
[3H]Inositol and 45CaC12 were obtained from New 
England Nuclear (Boston, MA). 
3. RESULTS AND DISCUSSION 
When aequorin-loaded adrenal glomerulosa 
cells are stimulated by 1 nM ~ote~in II, [Ca2’lc 
increases immediately after the addition of 
angiotensin II. As demonstrated in fig.lA, 
angiotensin II-mediated increase in [Ca2’Jc is only 
transient and the decrease in [Ca2’], is character- 
ized by two phases, a rapid fall followed by a se- 
cond slowly declining phase. [Ca”], returns to the 
resting value within 2 min. The second slow phase 
greatly depends on calcium influx since this phase 
disappears when cells are stimulated in medium 
containing 1 /cM extracellular calcium (fig.lB), 
under which angiotensin II-induced calcium influx 
is abolished 141. 
Pertussis toxin stimulates UP-ribosylation of 
Ew-subunit of Ni and, thereby, prevents agonist- 
induced dissociation of the protein into active 
subunits [ 131. Pertussis toxin is also known to 
ADP-ribosylate other GTP-binding proteins 
[24,25]. When pertussis toxin-pretreated cells are 
stimulated by angiotensin II, time course of 
changes in [Ca2’], is similar to that in pertussis 
toxin-untreated ceils stimulated in low calcium 
containing medium (fig.lC). Thus, pertussis toxin 
appears to modify ~giotensin II-mediated calcium 
influx, To examine this ~ssibility, aequorin- 
loaded cells are stimulated in calcium free medium 
and extracellular calcium is subsequently restored 
by adding calcium. In pertussis toxin-untreated 
cells, restoration of extracellular calcium in the 
presence ofangiotensin II results in a large increase 
in [Ca2+], (fig.2A). This increase is due to 
angiotensin II-induced calcium influx since 
restoration of calcium in the absence of angioten- 
sin II results in a gradual increase in ]Ca2% 
(fig.28). 
When pertussis town-pr~eated cells are 
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Fig.1. Effect of pertussis toxin pretreatment on ~giotensin G-induced changes in cytoplasmic free calcium 
con~ntration. A~uor~-loads eelis were incubated for 60 min with (C) or without (A,B) 100 ng/ml pertussis toxin. 
Cells were then stimulated by 1 nM angiotensin II as indicated by an arrow. Concentration of extracellular calcium was 
0.5 mM (A,C) or 1 CM (B). Aequorin bioluminescence is expressed as electric current. 
A 
All Ca 
B 
Ca 
c 
All Ca 
lmin 
Fig.2. Effect of pertussis toxin pretreatment on changes in cytopiasmic free calcium concentration induced by 
restoration of extracelhdar calcium. A~uorin-10~~ cells were incubated for 60 min with (C) or without (A,B) 
100 ng/ml pertussis toxin. Cells were then incubated in calcium free modified Hanks solution and 1 nM angiotensin 
II was added in (A,C) as indicated by an arrow. Extracellular caIcium concentration was then restored to 0.5 mM by 
adding caIcium chloride. 
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stimulated by angiotensin II in the absence of ex- 
tracellular calcium and then extracellular calcium 
is restored, [Ca”], increases only gradually 
(fig.2C). These results suggest hat pertussis toxin 
blocks angiotensin II-mediated calcium influx 
without affecting calcium release from an in- 
tracellular pool. To directly demonstrate the effect 
of pertussis toxin on calcium influx, calcium influx 
rate was determined by measuring initial uptake of 
45Ca into the cell. As shown in fig.3, pertussis tox- 
in pretreatment inhibited angiotensin II-induced 
calcium influx in a dose-dependent manner. Treat- 
ment with 100 ng/ml pertussis toxin almost com- 
pletely abolishes angiotensin II-mediated calcium 
influx. It is noteworthy that basal calcium influx is 
not affected by toxin pretreatment. In contrast to 
its action on calcium influx, pertussis toxin has lit- 
tle effect on polyphosphoinositide breakdown. As 
shown in table 1, angiotensin II elicits 3-fold in- 
crease in [‘HIIns-P3 in pertussis toxin-pretreated 
cells, which is comparable to that observed in 
toxin-untreated cells. 
Table 1 
Effect of pertussis toxin on angiotensin II stimulation of 
inositol trisphosphate production in adrenal 
glomerulosa cells 
Pertussis toxin Inositol trisphosphate 
(olo increase induced by 
angiotensin II) 
20 s 60s 
Untreated 290 f 60 304 zt 29 
Treated 302 f 53 320 f 40 
[‘H]Inositol-labeled cells were incubated for 60 min with 
or without 100 ng/ml pertussis toxin. Cells (lo7 cells in 
1 ml) were then stimulated for indicated time by 1 nM 
angiotensin II in the absence of lithium chloride. 
Radioactivity in inositol trisphosphate fraction is 
expressed as percent of that in unstimulated cells. 
Radioactivities in unstimulated cells were 1% f 42 dpm 
in pertussis toxin-untreated cells and 178 f 33 dpm in 
toxin-treated cells. Values are the mean f SE for 7 
determinations using 3 cell preparations 
The involvement of GTP-binding proteins in the 
action of angiotensin II on adrenal glomerulosa 
cells has been suggested by the following observa- 
tions: (i) binding of angiotensin II to its receptor is 
influenced by GTP [26]; (ii) angiotensin II 
decreases CAMP response to ACTH 1271. The 
results in the present study extend this notion by 
showing that angiotensin II-mediated calcium in- 
flux is sensitive to pertussis toxin. Unlike some 
other systems [14- 161, pertussis toxin does not af- 
fect agonist-induced activation of phospholipase 
C. Our present results agree with a previous report 
by Murayama et al. [18]. They have shown in 3T3 
fibroblasts that pertussis toxin inhibits angiotensin 
II-induced calcium uptake without inhibiting the 
activation of phospholipase C. Although pertussis 
toxin does not affect the activation of 
phospholipase C, we have recently found that 
angiotensin II-induced activation of phospholipase 
C observed in plasma membrane fraction is 
enhanced by GTP-yS (Kojima, I., unpublished). 
Thus, as demonstrated in hepatocytes [lo, 11,281, 
multiple GTP-binding proteins may be involved in 
signal transduction of angiotensin II in adrenal 
glomerulosa cells. 
01 10 100 
[Pertussis Toxin) (ng/md) 
Fig.3. Dose-response curve for pertussis toxin-induced 
inhibition of calcium influx. Adrenal glomerulosa cells 
were incubated for 60 min in the presence of various 
doses of pertussis toxin. Calcium influx rate was 
measured as described in section 2 in the presence (0) 
and absence (0) of 1 nM angiotensin II. Values are the 
mean f SE for 4 determinations. 
At present, the mechanism by which angiotensin 
II stimulates calcium influx is unknown. We have 
previously shown that angiotensin II and 
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potassium act on the common calcium channel, 
presumably voltage-dependent calcium channel 
141. In GHa cells, TRH induces an opening of 
voltage-dependent calcium channels by 
modulating potassium channels [29]. Given the 
fact that a pertussis toxin-sensitive protein is in- 
volved in the regulation of potassium channel by 
carbachol [ 171, it seems possible that GTP-binding 
protein acts as a transducer of angiotensin II ac- 
tion on calcium influx by modulating potassium 
channel. 
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